Sodium-glucose cotransporter 2 (SGLT2) inhibitors and risk of dementia in people with type 2 diabetes (T2D): A populationbased cohort study

被引：0
|
作者：
Tang, Huilin [1 ]
Shaaban, C. Elizabeth [2 ]
Wu, Yonghui [1 ]
Magoc, Tanja [1 ]
Donahoo, William Troy [1 ]
DeKosky, Steven [1 ]
Bian, Jiang [1 ]
Guo, Serena Jingchuan [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
803
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [41] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
    Abrahami, Devin
    Douros, Antonios
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (09) : E150 - E152
  • [42] SGLT2 Inhibitors and Parkinson's Disease (PD) Risk in Older Populations with Type 2 Diabetes (T2D)
    Guo, Serena Jingchuan
    Tang, Huilin
    Bian, Jiang
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 403 - 403
  • [43] Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
    Vivian, Eva
    DIABETES EDUCATOR, 2015, 41 : 5S - 18S
  • [44] The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 Diabetes
    Steen, Oren
    Goldenberg, Ronald M.
    CANADIAN JOURNAL OF DIABETES, 2017, 41 (05) : 517 - 523
  • [45] SGLT2 Inhibitors and Parkinson's Disease (PD) Risk in Older Populations with Type 2 Diabetes (T2D)
    Guo, Jingchuan
    Tang, Huilin
    Shao, Hui
    Lu, Ying
    Shi, Lizheng
    Fonseca, Vivian
    Guo, Yi
    Bian, Jiang
    DIABETES, 2024, 73
  • [46] Effectiveness of sodium glucose cotransporter 2 (SGLT2) inhibitors initiated in a community diabetes service
    Leverett, C.
    Hodgkinson, A.
    Sharpe, J.
    Rook, C.
    McGowan, D.
    Jones, M.
    Chamley, M.
    Freud, K. McAdam
    Karalliedde, J.
    DIABETIC MEDICINE, 2016, 33 : 164 - 164
  • [47] Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats
    Londzin, Piotr
    Brudnowska, Agata
    Kurkowska, Katarzyna
    Wilk, Katarzyna
    Olszewska, Karolina
    Ziembinski, Lukasz
    Janas, Aleksandra
    Cegiela, Urszula
    Folwarczna, Joanna
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 155
  • [48] Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
    Scheen, Andre J.
    NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (10) : 556 - 577
  • [49] Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad
    Preethika Ekanayake
    Christopher Hupfeld
    Sunder Mudaliar
    Current Diabetes Reports, 2020, 20
  • [50] Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad
    Ekanayake, Preethika
    Hupfeld, Christopher
    Mudaliar, Sunder
    CURRENT DIABETES REPORTS, 2020, 20 (12)
12345